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Abstract 
 
Abstract 
The heart is an organ heavily dependent on exogenous lipids for the oxidative production of 
adenosine-triphosphate (ATP) and therefore maintenance of normal cellular energy 
homeostasis. However, high energy flux organs such as the heart must closely match lipid 
import and utilization or otherwise lipids will accumulate in the cardiomyocytes. Intracellular 
lipid accumulation has detrimental effects on cardiomyocyte function and viability and results 
in development of lipotoxic cardiomyopathy. Different pathophysiological states such as 
congestive heart failure (CHF), myocardial ischemia and hypertrophy are associated with 
myocardial lipid accumulation. The heart, however, produces and secretes apolipoprotein B 
containing lipoproteins (apoB), which enables the cardiomyocyte to export lipids.  It has been 
proposed that apoB may be involved in cardioprotection by means of elimination of toxic 
intracellular lipids.  
An important part of the patologic cardiac remodelling in CHF is disturbed myocardial energy 
metabolism. The failing myocardium contains low levels of creatine (Cr), phosphocreatine 
(PCr), and ATP. Cr depletion in the heart may result in disturbed energy production, transfer 
and utilisation of chemical energy and therefore compromised left ventricular function.  
Growth hormone (GH) has been shown to exert numerous positive effects on the failing and 
remodelled heart suggesting that GH may be an additional agent in the treatment of CHF and 
myocardial infarction (MI). 
  
The aims of this thesis were:  
 
I. To investigate in vivo the effects of Cr depletion in mice on left ventricular function 
and morphology, energy metabolism and myocardial lipids. 
II. To investigate importance of endogenous lipoproteins in the heart for cardiac function, 
morphology and survival in the settings of acute and chronic myocardial infarction 
and doxorubicine induced acute heart failure. 
III. To investigate the effects of Growth hormone on arrhythmogenesis  
IV. To evaluate the predictive value of native cardiac reserve on outcome after myocardial 
infarction in mice 
 
 
Using a mouse model of chemically-induced Cr depletion we show in vivo that myocardial Cr 
depletion leads to disturbed energy metabolism, left ventricular dysfunction, pathologic 
remodeling and accumulation of intracellular triglycerides. These alterations are reversible 
upon the normalization of the creatine levels suggesting that creatine metabolism may be an 
important target for pharmacological interventions.   
Using transgenic animals we show that myocardial apoB may be a cardioprotective system 
which is activated during ischemia, pathologic remodeling and heart failure and may be 
important for survival in myocardial infarction and heart failure.  
We show that GH possess novel antiarrhythmic properties in the setting of acute MI which 
adds further evidence to the concept of GH as an additional pharmacological agent in the 
treatment of CHF and MI. 
We demonstrate that native cardiac reserve is a predictor of post-MI survival. 
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